BioSpace News Archive

The global thrombectomy devices market was estimated at $1.3 billion in 2020, and it is projected to garner around US$ 2.6 billion by 2030, growing at a CAGR of 7.4% from 2021 to 2030.

According to QY Research Medical, the global biosurgery market size is projected to reach around US$ 27,324.80 million by 2030 and it is growing at a CAGR of 9.5% from 2021 to 2030.

According to QY Research Medical, the contraceptives market size was estimated at US$ 26,321.5 million in 2020 and it is projected to surpass US$ 50,595.8 million by 2030, growing at a CAGR of 6.8% from 2020 to 2030.

Arcutis Biotherapeutics, Inc. announced results of a nationwide survey of adults with seborrheic dermatitis and the healthcare providers that treat them, designed to better understand their satisfaction and experience with currently available treatment options.

The global Ankylosing Spondylitis Drugs Market is forecast to reach USD 8,413.0 Million by 2028, according to a new report by Reports and Data.

The Peritoneal Dialysis Market is estimated to reach USD 5.85 Billion by 2028, according to a new report by Reports and Data.

Evusheld long-acting antibody combination retains neutralising activity against Omicron variants BA.4 and BA.5, according to new study from University of Oxford

Fernando J Bianco presented the data from the clinical study on EchoLaser for TPLA (transperineal laser ablation) at AUA in New Orleans (May 13-16).

EpiVax, Inc. (“EpiVax”) announces the publication “Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity” in Frontiers in Immunology, a collaboration with Massachusetts General Hospital’s (“MGH”) Vaccine and Immunotherapy Center, the Oxford Vaccine Group, Colorado State University, and Innatoss Laboratories B.V.

Agendia, Inc., a commercial-stage company focused on improving outcomes for breast cancer patients worldwide by providing physicians and patients with next-generation diagnostic and information solutions to inform optimized treatment decision-making, today announced 10,000 patients have been successfully enrolled in the FLEX Registry.